Get the Daily Brief

All action, no filler. BioBriefs delivers biotech’s 10 must-know updates, every morning.

Latest Biotech News

Advances in Plant and Agricultural Biotechnology Promote Sustainability and Crop Resilience

September 19, 2025

Emerging plant biology and agricultural biotech research unveils novel strategies to improve crop resilience and sustainability. Genetic and cellular studies trace developmental gradients in plant...

Roche Accelerates Liver Disease Therapy Race with $3.5 Billion 89bio Acquisition

September 18, 2025

Roche has agreed to acquire 89bio for up to $3.5 billion, securing the late-stage fatty liver disease drug candidate pegozafermin. This glycopegylated fibroblast growth factor 21 analogue,...

CRISPR-Based Tuberculosis Testing Advances With Oral Sample Assay

September 18, 2025

Researchers from Tulane University and Shenzhen Third People’s Hospital have developed ActCRISPR-TB, an enhanced CRISPR-Cas12a assay for tuberculosis detection from non-sputum samples like cheek...

Breakthrough AI Model Predicts Risk of 1,000 Diseases Over Two Decades

September 18, 2025

An innovative AI tool named Delphi-2M, developed using generative large language model architectures, can forecast the likelihood and timing of developing 1,258 diseases up to 20 years in advance....

Oral Microbiome Linked to Elevated Pancreatic Cancer Risk

September 18, 2025

Multiple studies led by NYU Langone Health have identified a significant association between the composition of oral bacteria and fungi and increased pancreatic cancer risk. A microbial risk score...

Cancer Immunotherapy Advances With Engineered Fusion Proteins and Prime Editors

September 18, 2025

Recent pioneering research has enhanced precision and efficacy in cancer therapies. A novel fusion protein developed by the University of Basel synergizes immune checkpoint blockade with...

Vaccine Program Turmoil: Former CDC Leadership Raises Alarm Over Policy Changes

September 18, 2025

Former CDC Director Susan Monarez testified before the Senate Health Committee describing her abrupt firing after refusing to endorse vaccine guideline changes without scientific evidence,...

Biogen and Partners Advance Novel Therapies and Facilities Amid Industry Shifts

September 18, 2025

Biogen is progressing key clinical-stage programs, including its acquisition of Alcyone Therapeutics for $85 million to enhance RNA drug delivery via implantable devices. The company also...

Innovations in Single-Cell Multiomics Reveal Deeper Biological Insights

September 18, 2025

BD Biosciences has unveiled enhanced multimodal assays combining protein and transcriptomic analyses to expand the resolution of single-cell studies, addressing limitations of previously RNA-only...

Cutting-Edge Soft Biofiber Implants and Neural Interfaces Advance Bioelectronics

September 18, 2025

Researchers have engineered flexible, stretchable biofiber electrodes—termed NeuroWorm—with a high density of sensing and stimulation elements in a soft, movable package that mimics earthworm...

Colossal Biosciences Secures Additional $120M for De-Extinction and Conservation Gene Editing

September 18, 2025

Colossal Biosciences expanded its Series C funding with an additional $120 million, bringing total funds raised to over $555 million. The Dallas-based firm is expanding its avian genetics group...

Roche Acquires 89bio for $3.5 Billion to Target Liver Disease

September 18, 2025

Roche has agreed to purchase 89bio in a deal valued up to $3.5 billion, acquiring the biotech's late-stage drug candidate pegozafermin for metabolic dysfunction-associated steatohepatitis (MASH)....

AI Drives Genome Design and Accelerates Gene Therapy Development

September 18, 2025

Researchers have harnessed artificial intelligence to design complete functional bacteriophage genomes and to assist CRISPR gene-editing experiments. AI models trained on millions of viral genomes...

Advancements in Cancer Immunotherapy and Targeted Therapeutics

September 18, 2025

Several studies reveal promising approaches to combat treatment-resistant cancers. Researchers developed antibody-bottlebrush conjugates that deliver high drug loads to tumors, potentially...

Breakthroughs in Rare Diseases and Precision Medicine

September 18, 2025

Regeneron achieved a pivotal phase 3 win with garetosmab for fibrodysplasia ossificans progressiva (FOP), an ultra-rare bone disease, reducing aberrant bone growth significantly and gearing up for...

Needle-Free Vaccine Delivery via Skin Stretching Technique

September 18, 2025

Researchers have demonstrated that mechanically stretching the skin activates immune surveillance and increases skin permeability, enabling more effective vaccine delivery without needles. Using a...

Novo Nordisk and Eli Lilly GLP-1 Drugs Show Mixed Market and Clinical Signals

September 18, 2025

Eli Lilly's oral GLP-1 diabetes pill orforglipron demonstrated superiority over Novo Nordisk’s Rybelsus in a phase 3 trial, edging blood sugar and weight loss. However, Novo Nordisk announced...

Bioprocessing Innovations and Manufacturing Investments

September 18, 2025

Bioprocessing advances are reshaping biologics manufacturing with intensified fed-batch processes delivering 5-10 fold productivity increases while simplifying operations, as presented by Sanofi's...

Novel Cancer Biomarkers and Diagnostic Tools

September 18, 2025

Precision oncology diagnostics have advanced with NucleoBio and PreCheck Health Services collaborating to develop Prostac, a qPCR-based assay evaluating long noncoding RNA biomarkers for prostate...

Environmental and Climate Impact Studies with Health Links

September 18, 2025

New research has linked global warming with increased health risks from wildfires, quantifying future impacts using machine learning frameworks. The Northern Hemisphere's summers of 2023-2025 are...